These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22777296)

  • 21. Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.
    Stagi S; Ferrari V; Ferrari M; Priolo M; Tartaglia M
    Front Endocrinol (Lausanne); 2022; 13():951331. PubMed ID: 36060964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone therapy in Noonan syndrome: growth response and characteristics.
    Westphal O
    Horm Res; 2009 Dec; 72 Suppl 2():41-5. PubMed ID: 20029236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height.
    Libraro A; D'Ascanio V; Cappa M; Chiarito M; Digilio MC; Einaudi S; Grandone A; Maghnie M; Mazzanti L; Mussa A; Patti G; Scarano E; Spinuzza A; Vannelli S; Wasniewska MG; Ferrero GB; Faienza MF
    Front Endocrinol (Lausanne); 2021; 12():761171. PubMed ID: 35002956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study.
    Şıklar Z; Genens M; Poyrazoğlu Ş; Baş F; Darendeliler F; Bundak R; Aycan Z; Savaş Erdeve Ş; Çetinkaya S; Güven A; Abalı S; Atay Z; Turan S; Kara C; Can Yılmaz G; Akyürek N; Abacı A; Çelmeli G; Sarı E; Bolu S; Korkmaz HA; Şimşek E; Çatlı G; Büyükinan M; Çayır A; Evliyaoğlu O; İşgüven P; Özgen T; Hatipoğlu N; Elhan AH; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):305-12. PubMed ID: 27125300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
    Simon D; Alberti C; Alison M; Le Henaff L; Chevenne D; Boizeau P; Canal A; Ollivier G; Decostre V; Jacqz-Aigrain E; Carel JC; Czernichow P; Hogrel JY
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2746-54. PubMed ID: 23626006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excellent growth response to growth hormone therapy in a child with PTPN11-negative Noonan syndrome and features of growth hormone resistance.
    Walton-Betancourth S; Martinelli CE; Thalange NK; Dyke MP; Acerini CL; White S; Camacho-Hübner C; Savage MO
    J Endocrinol Invest; 2007 May; 30(5):439-41. PubMed ID: 17598979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of the PTPN11 gene in Egyptian patients with Noonan syndrome.
    Essawi ML; Ismail MF; Afifi HH; Kobesiy MM; El Kotoury A; Barakat MM
    J Formos Med Assoc; 2013 Nov; 112(11):707-12. PubMed ID: 24183200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic identification of a case of Noonan syndrome and treatment with growth hormone].
    Pi G; Zúñiga A; Gastaldo E; Ortiz M
    Med Clin (Barc); 2014 Apr; 142(8):378-9. PubMed ID: 24054841
    [No Abstract]   [Full Text] [Related]  

  • 31. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
    Esen I; Demirel F; Tepe D; Kara O; Koc N
    Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of growth hormone therapy on adult height in noonan syndrome: a systematic review.
    Giacomozzi C; Deodati A; Shaikh MG; Ahmed SF; Cianfarani S
    Horm Res Paediatr; 2015; 83(3):167-76. PubMed ID: 25721697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features, genetic detection and therapeutic response to rhGH of children with Noonan syndrome: an analysis of 12 cases.
    Shangguan H; Xu Y; Chen R
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):500-505. PubMed ID: 34704406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of growth hormone therapy in children with noonan syndrome: a review of the evidence.
    Noonan JA; Kappelgaard AM
    Horm Res Paediatr; 2015; 83(3):157-66. PubMed ID: 25503994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hotspots in PTPN11 Gene Among Indian Children With Noonan Syndrome.
    Narayanan DL; Pandey H; Moirangthem A; Mandal K; Gupta R; Puri RD; Patil SJ; Phadke SR
    Indian Pediatr; 2017 Aug; 54(8):638-643. PubMed ID: 28607217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth patterns of patients with Noonan syndrome: correlation with age and genotype.
    Cessans C; Ehlinger V; Arnaud C; Yart A; Capri Y; Barat P; Cammas B; Lacombe D; Coutant R; David A; Baron S; Weill J; Leheup B; Nicolino M; Salles JP; Verloes A; Tauber M; Cavé H; Edouard T
    Eur J Endocrinol; 2016 May; 174(5):641-50. PubMed ID: 26903553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between exon 3 polymorphism of growth hormone receptor gene and the responses to rhGH therapy.
    Wei Y; Zheng R; Zhou Y; Wang J; Bao P
    Int J Clin Exp Pathol; 2015; 8(6):7371-7. PubMed ID: 26261638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy.
    McWilliams GD; SantaCruz K; Hart B; Clericuzio C
    Am J Med Genet A; 2016 Jan; 170A(1):195-201. PubMed ID: 26377682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noonan syndrome, the Ras-MAPK signalling pathway and short stature.
    Binder G
    Horm Res; 2009 Apr; 71 Suppl 2():64-70. PubMed ID: 19407499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between vitamin D receptor (VDR) polymorphisms and the efficacy of recombinant human growth hormone (rhGH) treatment in children with idiopathic short stature.
    Wang W; Luo XP; Cai LX; Cui ZR; Luo XY; Luo RK
    Genet Mol Res; 2015 Sep; 14(3):10507-14. PubMed ID: 26400282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.